Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.
GenomeWeb reports on GHTC's call to World Health Organization to establish an essential diagnostics list, quoting GHTC policy officer Matt Robinson.
GHTC sent a letter to the World Health Organization's (WHO) Assistant Director-General of Health Systems and Innovation urging WHO to support the establishment of an essential diagnostics list.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
The 140th session of the World Health Organization (WHO) Executive Board (EB) closed last week with a shortlist of three candidates for the WHO Director General position and progress on key global health R&D issues.